|
Market Closed -
Other stock markets
|
After market 19:49:25 | |||
| 58.70 EUR | +0.72% |
|
58.64 | -0.10% |
| 12-02 | AKZO NOBEL NV : Upgraded to Buy by JP Morgan | ZD |
| 10-30 | Akzo Nobel to Exit India, Plans Sale of Akzo Nobel India | CI |
| Capitalization | 9.95B 10.52B 9.25B 8.25B 14.76B 891B 16.34B 114B 42.44B 365B 39.48B 38.64B 1,580B | P/E ratio 2024 * |
16.6x | P/E ratio 2025 * | 14.6x |
|---|---|---|---|---|---|
| Enterprise value | 13.75B 14.53B 12.77B 11.39B 20.38B 1,231B 22.56B 158B 58.61B 504B 54.53B 53.37B 2,181B | EV / Sales 2024 * |
1.29x | EV / Sales 2025 * | 1.23x |
| Free-Float |
98.43% | Yield 2024 * |
3.37% | Yield 2025 * | 3.53% |
More valuation ratios
* Estimated data
More news
Last Transcript: Akzo Nobel N.V.
More press releases
More news
| 1 day | +0.72% | ||
| 1 week | +6.42% | ||
| Current month | +6.15% | ||
| 1 month | +1.07% | ||
| 3 months | +0.65% | ||
| 6 months | -6.80% | ||
| Current year | -21.55% |
1 week
54.72
58.70
1 month
54.6860.16
Current year
52.8275.24
1 year
52.8275.30
3 years
52.8299.92
5 years
45.73108.45
10 years
45.73108.45
| Director | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 31/10/2022 | |
Maarten de Vries
DFI | Director of Finance/CFO | 62 | 31/12/2017 |
Kenny Chae
IRC | Investor Relations Contact | - | 31/07/2021 |
| Manager | Title | Age | Since |
|---|---|---|---|
Byron Grote
BRD | Director/Board Member | 76 | 28/04/2014 |
Dick M. Sluimers
BRD | Director/Board Member | 71 | 21/04/2015 |
Patrick Thomas
BRD | Director/Board Member | 67 | 29/11/2017 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.22% | 2 M€ | -3.47% | - | |
| 0.60% | 20 M€ | +16.82% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +0.72% | +6.42% | -17.76% | -39.46% | 10.48B | ||
| -1.43% | -2.72% | +36.60% | +13.33% | 98.41B | ||
| -0.82% | +1.11% | -11.85% | -23.53% | 29.39B | ||
| -0.29% | -1.59% | -23.24% | -21.16% | 27.85B | ||
| -0.92% | -1.21% | +30.92% | +43.67% | 17.84B | ||
| +0.10% | +5.19% | -2.56% | -11.89% | 16.39B | ||
| -0.84% | -0.42% | +25.40% | +27.54% | 8.85B | ||
| +0.98% | -1.47% | -17.46% | -20.55% | 6.58B | ||
| -0.38% | -2.45% | -9.68% | -43.15% | 3.45B | ||
| -0.09% | +1.02% | -12.98% | -29.91% | 2.65B | ||
| Average | -0.28% | +0.61% | -0.26% | -10.51% | 22.19B | |
| Weighted average by Cap. | -0.81% | +0.46% | +13.40% | +0.37% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 10.67B 11.28B 9.92B 8.84B 15.83B 956B 17.52B 123B 45.52B 392B 42.35B 41.44B 1,694B | 10.95B 11.57B 10.17B 9.07B 16.23B 980B 17.97B 126B 46.68B 402B 43.43B 42.5B 1,737B |
| Net income | 597M 631M 555M 495M 886M 53.47B 980M 6.86B 2.55B 21.91B 2.37B 2.32B 94.77B | 670M 709M 623M 556M 994M 60.03B 1.1B 7.71B 2.86B 24.59B 2.66B 2.6B 106B |
| Net Debt | 3.79B 4.01B 3.52B 3.14B 5.62B 340B 6.23B 43.6B 16.17B 139B 15.05B 14.73B 602B | 3.52B 3.72B 3.27B 2.92B 5.22B 315B 5.78B 40.46B 15.01B 129B 13.96B 13.67B 559B |
More financial data
* Estimated data
Employees
35,400
Sector
Commodity Chemicals
Calendar
29/01/2025
- Q4 2024 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/12/24 | 58.70 € | +0.72% | 452,663 |
| 04/12/24 | 58.28 € | +0.31% | 320,128 |
| 03/12/24 | 58.10 € | +1.01% | 375,509 |
| 02/12/24 | 57.52 € | +4.01% | 561,471 |
| 29/11/24 | 55.30 € | +0.25% | 374,761 |
Real-time Euronext Amsterdam, December 05, 2024 at 04:35 pm
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
58.28EUR
Average target price
73.53EUR
Spread / Average Target
+26.16%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AKZA Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition